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The loss index (late loss/acute gain) was identical in the 3 groups. In con-
clusion, in this quantitative study, the deletion polymorphism of the ACE
gene did not influence the occurence of restenosis after PTCA.
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Right Ventricular Ejection Fraction is Superior to
MV02 in Predicting Event-free Survival in
Advanced Heart Failure
Thomas Di Salvo, Michael Mathier, Dennis McNamara, Marc Semigran, G.
William Dec. Massachusetts General Hospital and Harvard Medical School, Boston, MA
Jon A. Kobashigawa, Michael P. Gleeson, Hillel Laks, Jaime Moriguchi,
Nobuyuki Kawata, Michele Hamilton, Antoine Hage, Davis Drinkwater. UCLA
Medical Center, Los Angeles, CA
Steroid-free immunosuppression has been reported to be successful in se-
lect cardiac transplant recipients. Further reduction of immuno-suppression
meditation (using cyclosporine alone) has been reported; however, there is
concern regarding long term outcome. In our institution, since 1989, 16 car-
diac transplant patients on double-immunosuppression (cyclosporine and
azathioprine) whose WBC decreased to less than 4,000 were also taken
off azathioprine and maintained on mono-immunosuppression (cyclosporine
alone). Five year actuarial survival for this group is 92%, and there has been
no evidence for transplant coronary artery disease (defined as any luminal
irregularity) in any of the annual coronary angiograms. Comparison of actu-
arial survival curves between mono-immunosuppression patients and triple-
immunosuppression patients is as follows:
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Functional capacity assessed by maximum oxygen consumption (MV02)
and percent age-sex adjusted MV02 achieved (% MV02) predicts survival
in heart failure (HF). To determine the exercise parameters which best pre-
dict survival, 66 patients with advanced HF (mean age 51 ± 9.9 mean ± SO;
58% NYHA III, 18% NYHA IV; mean LVEF 0.22 ± 0.07) underwent simultane-
ous cardiopulmonary exercise testing and first-pass rest/exercise radionu-
c1ide ventriculography during transplant (TX) evaluation. Mean MV02 was
11.8 ± 4.2 mllkg/min, mean % MV02 38 ± 11.9%. During median follow-
up 93 weeks, 16/66 patients (25%) died. Univariate predictors of survival
included restRVEF > 0.35, exRVEF > 0.35, and % MV02 > 45% (all p <
0.05). In a multivariate proportional hazards survival model, exRVEF > 0.35
(p < 0.01) and % MV02 > 45% (p = 0.01) were selected as predictors. 28/66
patients (42%) reached the combined end-point of death or hospitalization
for inotropic/mechanical bridging (IN) to cardiac TX. Univariate predictors of
IN-free survival included restRVEF > 0.35 (p = 0.01), exRVEF > 0.35 (p <
0.01). NYHAC (p < 0.05), mid % MV02 > 45% (p = 0.05). exRVEF > 0.35
(p = 0.01) was the only predictor of IN-free survival selected in a multivari-
ate proportional hazards model. MV02, CI rest/exercise, LVEF rest/exercise,
exercise-related rise or fall> 0.05 in LVEF or RVEF were not predictive of sur-
vival or IN-free survival in any univariate or multivariate analysis. Conclusions:
1) RVEF > 0.35 at rest and exercise is a more potent predictor of survival in
advanced HF than MV02 or % MV02; 2) % MV02 but not MV02predicts
survival in advanced HF; 3) neither % MV02 nor MV02predict survival to the
combined end-point death or admission for inotropic or mechanical support.
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Cytomegalovirus Infection Increases Neointimal
Formation in the Rat Model of Balloon Injury
Yi Fu Zhou, Matie Shou, Raul Guzman, Esther Guetta, Toren Finkel, Stephen
E. Epstein. National Institutes of Health, Bethesda, MD
Does Insertion/Deletion Polymorphism of the
Angiotensin Converting Enzyme Influence the
Occurence of Restenosis After Percutaneous
Transluminal Coronary Angioplasty?
Martial Hamon 1, Christophe Bauters 1, Carole Amant 2, Eugene Mc Fadden 1,
Nicole Helbeque 2, Jean-Marc Lablanche 1, Michel Bertrand 1, Philippe Amouyel 2.
1 University and CHRU de lille; 2 Institut Pasteur de lille
Conclusion: These data indicate that the gender difference in myointimal
proliferation after vascular injury is estrogen dependent. These findings have
direct implications for the prevention and treatment of vascular disease in
human subjects.
Previous studies have suggested that cytomegalovirus (CMV) infection may
playa role in the development of atherosclerosis. A recent study we con-
ducted in patients who developed restenosis following coronary angio-
plasty suggested that the presence of CMY. an extremely common human
pathogen, was a possible contributing cause of restenosis. To determine
whether CMV can increase injury-induced neointimal formation in an ani-
mal model, we measured the neointimal response to injury of the rat carotid
artery following rat CMV (RCMV) infection. Standard left carotid balloon in-
jury was performed on thirty male Spraque-Oawley rats (400-450 g). One day
after injury, fifteen olthe balloon injured rats received an intraperitoneal injec-
tion of approximately 106 active viral particles/ml of RCMV (Priscott strain),
while another fifteen control rats received an intraperitoneal injection of nor-
mal saline. Six weeks later, the salivary glands, spleen and left carotid arteries
were harvested. To assay for the presence of replicating virus, serial dilution
of tissue homogenates were used to inoculate a monolayer of permissive
indicator cells (rat embryonic fibroblast) and the presence or absence of cy-
topathic effect was determined. In infected animals, infectious viral parti-
cles could routinely be recovered from both salivary glands and spleen, but
only occasionally from vascular tissues. Assessment of the neointimal to me-
dial (N/M) ratio by computerized image analyzer revealed that the neointimal
thickness of RCMV infected animals was nearly 40% greater than that of
control animals (N/M ratio 1.62 ± 0.56 vs 1.17 ± 0.61; P < 0.05).
Conclusion: RCMV infection of immunocompetent adult rats increases the
neointimal response to vascular injury. This finding provides further evidence
suggesting that CMV may playa crucial role in the development of restenosis
in patients undergoing angioplasty.
The insertion/deletion (I/O) polymorphism of the angiotensin converting en-
zyme (ACE) is related to the pathogenesis of coronary artery disease. The
deletion allele is strongly associated with the level of circulating ACE and is a
potent risk factor for myocardial infarction (MI). Recently, the deletion allele
was also associated with the occurrence of visually diagnosed restenosis
after percutaneous transluminal coronary angioplasty (PTCAI in a selected
population of patients with acute MI.
We investigated the influence of the ACE 110 polymorphism on the oc-
currence of restenosis after PTCA, using quantitative coronary angiography.
ACE lID genotypes were analysed in 118 consecutive patients with one ves-
sel disease. All of them underwent PTCA and had a systematic angiographic
follow-up (Fup). Coronary angiograms were analysed before and after PTCA,
and at Fup (7.5 ± 3 months).
Before PTCA, no clinical or angiographic differences were detected be-
tween the three groups of genotypes. At Fup, the absolute minimal lumen
diameter and percent stenosis were similar in the 3 groups of genotypes.
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Conclusion: Mono-immunosuppression (cyclosporine alone) appears suc-
cessful in select cardiac transplant recipients. The low risk for transplant
coronary artery disease may be due to a lowering of associated risk factors
and the selection of an "immuno-privileged" patient population.
